Polyclonal anti-tumor response directed against many tumor antigens including hTERT, G250, and oncofetal antigen were detected in 6 of the 7 evaluable patients following immunization with the total tumor mRNA-expressing DCs7 out of 10 immunized patients showed a prolonged mean overall follow-up of 19.8 months. The gene discussed is CA9; the disease is neoplasm.